Paper · 15857504
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
1 to 20 of 27
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42748134 | From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells. | PLoS One | 2026 | https://conductscience.org/library/papers/42748134 | PubMed |
| 40366255 | E-Cadherin Is a Structuring Component of Invadopodia in Pancreatic Cancer. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40366255 | PubMed |
| 36902125 | Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902125 | PubMed |
| 35155241 | Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells. | Front Oncol | 2022 | https://conductscience.org/library/papers/35155241 | PubMed |
| 32648934 | In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer. | Biotechnol Bioeng | 2020 | https://conductscience.org/library/papers/32648934 | PubMed |
| 29671772 | Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29671772 | PubMed |
| 28965853 | Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28965853 | PubMed |
| 28758107 | Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer. | Medicines (Basel) | 2017 | https://conductscience.org/library/papers/28758107 | PubMed |
| 28460441 | Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies. | Oncotarget | 2017 | https://conductscience.org/library/papers/28460441 | PubMed |
| 28009978 | The secretion and biological function of tumor suppressor maspin as an exosome cargo protein. | Oncotarget | 2017 | https://conductscience.org/library/papers/28009978 | PubMed |
| 26958085 | Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression. | J Cancer | 2016 | https://conductscience.org/library/papers/26958085 | PubMed |
| 26404901 | Microfluidic cytometric analysis of cancer cell transportability and invasiveness. | Sci Rep | 2015 | https://conductscience.org/library/papers/26404901 | PubMed |
| 25701047 | COX-2 dependent regulation of mechanotransduction in human breast cancer cells. | Cancer Biol Ther | 2015 | https://conductscience.org/library/papers/25701047 | PubMed |
| 25184143 | E-cadherin and gastric cancer: cause, consequence, and applications. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25184143 | PubMed |
| 24291763 | Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. | Int J Biochem Cell Biol | 2014 | https://conductscience.org/library/papers/24291763 | PubMed |
| 23689139 | Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization. | Cancer Lett | 2013 | https://conductscience.org/library/papers/23689139 | PubMed |
| 23386909 | In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene. | J Cancer | 2013 | https://conductscience.org/library/papers/23386909 | PubMed |
| 23320987 | TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity. | J Hematol Oncol | 2013 | https://conductscience.org/library/papers/23320987 | PubMed |
| 22937154 | Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. | PLoS One | 2012 | https://conductscience.org/library/papers/22937154 | PubMed |
| 22440943 | E-cadherin's dark side: possible role in tumor progression. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22440943 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/15857504/cited_by